chr16-27067006-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001145545.2(C16orf82):​c.11C>T​(p.Pro4Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,367,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 4/4 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00074 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 0 hom. )

Consequence

C16orf82
NM_001145545.2 missense

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.00

Publications

2 publications found
Variant links:
Genes affected
C16orf82 (HGNC:30755): (chromosome 16 open reading frame 82)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C16orf82NM_001145545.2 linkc.11C>T p.Pro4Leu missense_variant Exon 1 of 1 ENST00000505035.3 NP_001139017.1 Q7Z2V1A0A5F9ZHF3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C16orf82ENST00000505035.3 linkc.11C>T p.Pro4Leu missense_variant Exon 1 of 1 6 NM_001145545.2 ENSP00000500329.2 A0A5F9ZHF3

Frequencies

GnomAD3 genomes
AF:
0.000749
AC:
114
AN:
152216
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00132
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000747
AC:
186
AN:
249044
AF XY:
0.000807
show subpopulations
Gnomad AFR exome
AF:
0.000194
Gnomad AMR exome
AF:
0.000319
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000465
Gnomad NFE exome
AF:
0.00120
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.00110
AC:
1333
AN:
1215366
Hom.:
0
Cov.:
30
AF XY:
0.00110
AC XY:
660
AN XY:
602322
show subpopulations
African (AFR)
AF:
0.000380
AC:
10
AN:
26300
American (AMR)
AF:
0.000268
AC:
10
AN:
37288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16896
East Asian (EAS)
AF:
0.00
AC:
0
AN:
16806
South Asian (SAS)
AF:
0.00119
AC:
99
AN:
83226
European-Finnish (FIN)
AF:
0.0000615
AC:
2
AN:
32544
Middle Eastern (MID)
AF:
0.000894
AC:
4
AN:
4474
European-Non Finnish (NFE)
AF:
0.00124
AC:
1180
AN:
953828
Other (OTH)
AF:
0.000636
AC:
28
AN:
44004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000742
AC:
113
AN:
152334
Hom.:
0
Cov.:
32
AF XY:
0.000806
AC XY:
60
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000240
AC:
10
AN:
41580
American (AMR)
AF:
0.000327
AC:
5
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00132
AC:
90
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000983
Hom.:
2
Bravo
AF:
0.000559
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 11, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.11C>T (p.P4L) alteration is located in exon 1 (coding exon 1) of the C16orf82 gene. This alteration results from a C to T substitution at nucleotide position 11, causing the proline (P) at amino acid position 4 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
23
DANN
Benign
0.80
PhyloP100
1.0
PromoterAI
0.0038
Neutral
Mutation Taster
=98/2
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200270667; hg19: chr16-27078327; API